List view / Grid view
14 July 2022 By Eurofins Discovery
Sign up for our free live webinar to learn how to accelerate screening and Structure Activity Relationship (SAR) analysis in the targeted protein degradation (TPD) drug discovery field.
ON-DEMAND By Charles River
This webinar highlights imaging as well as cognitive and physiological testing of AD models...
ON-DEMAND By IntelliCyt Corporation
In this webinar, Belen Ybarrondo, Ph.D and Thomas Duensing, Ph.D discuss the need for robust high content tools for current immunotherapeutic approaches, and how IntelliCyt's iQue Screener PLUS can give functional efficacy of immuno-oncology therapies...
ON-DEMAND By Charles River
This webinar reviews successful high throughput screening programs to provide an overview of the process from assay development to final data package...
ON-DEMAND By Charles River
Charles River highlights new kinetic PET imaging and AIF as new tools in our comprehensive portfolio of imaging and associated ex vivo techniques...
ON-DEMAND By IntelliCyt Corporation
In this webinar, Belen Ybarrondo, Ph.D and Thomas Duensing, Ph.D discuss the challenges faced with antibody screening and how the iQue Screener can give an evaluation of cell killing mechanism, screening for immune checkpoint inhibitors and more...
ON-DEMAND By Illumina
In this webinar, we focus on the use of microarray technology in drug development...
ON-DEMAND By Charles River
Ligand-gated ion channels including, GABAA, NMDA, and nicotinic acetylcholine receptors, are important therapeutic targets in neurological disorders...
ON-DEMAND By Avacta Life Sciences
In this webinar we discuss Affimer® technology, a novel antibody mimetic and powerful antibody alternative...
ON-DEMAND By Charles River
This webinar describes an approach to phenotypic discovery through bioprofiling in human primary cell-based assays across several disease areas (case study)...
ON-DEMAND By IntelliCyt
Identification of antibodies against challenging targets using high throughput multiplex-screening approaches...
ON-DEMAND By IntelliCyt
Immunology Screening on the iQue Screener: Assays for Immune-Modulators and Immunotherapy...
ON-DEMAND By Charles River
The evolution of tools to analyze motor deficits in animal models and how Charles River is working to support the discovery of new Parkinson’s therapies...
ON-DEMAND By Charles River
This webinar discusses the gap between the compound profile of the industry’s current libraries and that of successful drugs approved in recent years...
ON-DEMAND By Cisbio Bioassays & Trevena, Inc.
TRV027 is a biased ligand; the in vitro profile and its translation into in vivo pharmacology is discussed during this webinar.
ON-DEMAND By BMG Labtech GmbH
Due to their role in signal transmission from the outside to the inside of a cell, G-protein coupled receptors (GPCRs) are prominent drug targets.
